Table 2 Choice of pharmacotherapy by group
From: An individually-tailored smoking cessation intervention for rural Veterans: a pilot randomized trial
Medicationa | Quitline Referral | Tailored interventionb | Total |
|---|---|---|---|
n (%) | n (%) | n (%) | |
Any use of productc | |||
 Nicotine patch | 18 (56.3) | 12 (38.7) | 30 (47.6) |
 Nicotine gum | 10 (31.3) | 7 (22.6) | 17 (27.0) |
 Nicotine lozenge | 9 (28.1) | 9 (29.0) | 18 (28.6) |
 Bupropion | 8 (25.0) | 5 (16.1) | 13 (20.6) |
 Varenicline | 10 (31.3) | 13 (41.9) | 23 (36.5) |
Monotherapy | |||
 Nicotine replacement therapy | 6 (18.8) | 2 (6.5) | 8 (12.7) |
  Nicotine patch | 2 (6.3) | 0 (0.0) | 2 (3.2) |
  Nicotine gum | 3 (9.4) | 0 (0.0) | 3 (4.8) |
  Nicotine lozenge | 1 (3.1) | 2 (6.5) | 3 (4.8) |
 Bupropion | 1 (3.1) | 1 (3.2) | 2 (3.2) |
 Varenicline | 10 (31.3) | 13 (41.9) | 23 (36.5) |
Combination therapy | |||
 Any combination NRT | 12 (37.5) | 11 (35.5) | 23 (36.5) |
  Nicotine patch + nicotine gum | 5 (15.6) | 5 (16.1) | 10 (15.9) |
  Nicotine patch + nicotine lozenge | 7 (21.9) | 6 (19.4) | 13 (20.6) |
 Any bupropion + NRT combination | 7 (21.9) | 4 (12.9) | 11 (17.5) |
  Nicotine patch + bupropion | 4 (12.5) | 1 (3.2) | 5 (7.9) |
  Nicotine gum + bupropion | 2 (6.3) | 2 (6.5) | 4 (6.3) |
  Nicotine lozenge + bupropion | 1 (3.1) | 1 (3.2) | 2 (3.2) |